首页|miR-429-3p mediates memory decline by targeting MKP-1 to reduce surface GluA1-containing AMPA receptors in a mouse model of Alzheimer's disease

miR-429-3p mediates memory decline by targeting MKP-1 to reduce surface GluA1-containing AMPA receptors in a mouse model of Alzheimer's disease

扫码查看
Alzheimer's disease(AD)is a leading cause of dementia in the elderly.Mitogen-activated protein kinase phosphatase 1(MKP-1)plays a neuroprotective role in AD.However,the molecular mech-anisms underlying the effects of MKP-1 on AD have not been extensively studied.MicroRNAs(miR-NAs)regulate gene expression at the post-transcriptional level,thereby repressing mRNA translation.Here,we reported that the microRNA-429-3p(miR-429-3p)was significantly increased in the brain of APP23/PS45 AD model mice and N2AAPP AD model cells.We further found that miR-429-3p could downregulate MKP-1 expression by directly binding to its 3'-untranslated region(3'UTR).Inhibition of miR-429-3p by its antagomir(A-miR-429)restored the expression of MKP-1 to a control level and conse-quently reduced the amyloidogenic processing of APP and Aβ accumulation.More importantly,intranasal administration of A-miR-429 successfully ameliorated the deficits of hippocampal CA1 long-term potenti-ation and spatial learning and memory in AD model mice by suppressing extracellular signal-regulated ki-nase(ERKl/2)-mediated GluA1 hyperphosphorylation at Ser831 site,thereby increasing the surface expression of GluA1-containing α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors(AMPARs).Together,these results demonstrate that inhibiting miR-429-3p to upregulate MKP-1 effectively improves cognitive and synaptic functions in AD model mice,suggesting that miR-429/MKP-1 pathway may be a novel therapeutic target for AD treatment.

Alzheimer's diseaseMKP-1miR-429-3pAMPA receptorLearning and memoryLong-term potentiation

Man Luo、Yayan Pang、Junjie Li、Lilin Yi、Bin Wu、Qiuyun Tian、Yan He、Maoju Wang、Lei Xia、Guiqiong He、Weihong Song、Yehong Du、Zhifang Dong

展开 >

Pediatric Research Institute,Ministry of Education Key Laboratory of Child Development and Disorders,National Clinical Research Center for Child Health and Disorders,China International Science and Technology Cooperation Base of Child Development and Critical Disorders,Chongqing Key Laboratory of Translational Medical Research in Cognitive Development and Learning and Memory Disorders,Children's Hospital of Chongqing Medical University,Chongqing 400014,China

Department of Anatomy,Basic Medical College,Chongqing Medical University,Chongqing 400016,China

Townsend Family Laboratories,Department of Psychi

Institute for Brain Science and Disease of Chongq

展开 >

National Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNatural Science Foundation of Chongqing,ChinaNatural Science Foundation of Chongqing,ChinaNatural Science Foundation of Chongqing,ChinaScientific and Technological Innovation Project for the Construction of Chengdu-Chongqing Economic Circle,ChinaCQMU Program for Youth Innovation in Future Medicine,China

32371030823711948207139582001158CSTB2022NSCQ-LZX0010cstc2021ycjhbgzxm0186Chi naKJCX ZD2020021W0044

2024

药学学报(英文版)

药学学报(英文版)

CSTPCD
ISSN:
年,卷(期):2024.14(2)
  • 66